Mortality and venous thromboembolism (VTE) are major risks for patients with hematological malignancies. However, they are commonly underrepresented in major clinical trials of VTE. Treatment decisions are further complicated by the unique characteristics they frequently exhibit, such as thrombocytopenia. In addition to discussing treatment challenges, knowledge gaps, and future directions, our goal in this narrative review is to provide an overview of the epidemiology and risk factors of mortality in patients with hematological malignancies and VTE.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11636961PMC
http://dx.doi.org/10.4081/btvb.2024.119DOI Listing

Publication Analysis

Top Keywords

patients hematological
12
hematological malignancies
12
venous thromboembolism
8
mortality patients
8
thromboembolism mortality
4
malignancies mortality
4
mortality venous
4
thromboembolism vte
4
vte major
4
major risks
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!